Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin

Full text for this resource is not available from the Research Repository.

Tan, M, Choong, Peter F. M and Dass, Crispin R (2010) Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin. Advanced Materials Research, 93-94 (2010). pp. 703-706. ISSN 1022-6680 (print) 1662-8985 (online)


Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were formed. Multiple optimisation steps produced DMPs which caused tumour cell death. Treatment of mice bearing tumours with DMP decreased tumour growth and spread, with no visible side-effects. There are plans to evaluate this delivery vehicle more closely towards clinical development and testing.

Dimensions Badge

Altmetric Badge

Item type Article
DOI 10.4028/
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions)
Keywords ResPubID21869, cancer, chitosan, complex, delivery, doxorubicin
Citations in Scopus 1 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login